Prefilled Syringes Global Market

–Forecast to 2028

Prefilled Syringes Global Market estimated to be worth of $10.2 billion by 2028

IQ4I Research & Consultancy published a new report on “Prefilled Syringes Global
Market – Forecast To 2028” This report analyzes and studies the overall market, major
Drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and
Rest of the World.

IQ4I’s Report Contains 110 market data tables and 126 figures spread through 664
pages and an exhaustive TOC on “Prefilled Syringes Global Market”, [By Material
(Glass, Polymer); By Design (Single Chamber, Dual Chamber); By Closure System
(Staked Needle PFS, Luer Lock PFS, Non-Luer lock PFS); By Application (Heparin
PFS, Vaccine PFS, Therapeutic Drugs PFS, Surgical Application PFS, Hyaluronic Acid
PFS, Diluent PFS and Other Applications PFS); By Product (Complete Prefilled
Syringes, Consumables, Accessory Devices); By Molecule Type (Small Molecule,
Large Molecule); By Usability (Single Use, Reusable); By Route of Administration
(Subcutaneous PFS, Intravenous PFS, Intramuscular PFS and Other Routes PFS); By
Region (North America, Europe, Asia-Pacific and Rest of the World)]

Prefilled syringes (PFS) are the sterile primary packaging systems or sealed containers that
can also function as efficient drug delivery systems for the pre-loaded desired dose of
parenteral pharmaceutical product. By engineering easier usability and improved patient
experience into prefilled syringes, various prefilled syringe products have gained an
unrivalled position as the most preferred or attractive container of choice for delivering
injectable medical products in the market and have evolved to become the gold-standard for
safer and easier self-administration of medications, especially the highly viscous
biopharmaceuticals. These immediate packaging containers incorporated with proprietary
traits capable of improving administration of a therapy, clinical outcomes and even regulatory
claims have currently evolved to become a status-quo product among the pharmaceutical
companies that help the firms to further create, sustain or enhance their revenue streams
during the mature years of their pharmaceutical products lifecycle.

According to IQ4I estimations, the prefilled syringes global market is expected to reach
$10,273.8 million by 2028, growing at a high single digit CAGR from 2021 to 2028. Factors
like increasing popularity of extremely handy, safer, convenient and dose-accurate prefilled
syringes among patients and healthcare professionals, increasing predisposition of
pharmaceutical companies towards prefilled syringes for cost-savings and brand
differentiation, preferential adoption of prefilled syringes for the delivery of various highly
viscous and sensitive biopharmaceuticals, emergence of technologically advanced prefillable
syringe products, persistently escalating prevalence of chronic and infectious diseases and
allergies, increasing number of prefilled syringes being approved by regulatory authorities

IQ4I Research & Consultancy Pvt. Ltd. Page 1

Prefilled Syringes Global Market

–Forecast to 2028

across the globe and the trend of collaboration and investments among the prefillable
syringe manufacturers are propelling the prefilled syringe market growth. Technical
challenges associated with the sophisticated manufacturing process of prefillable syringes,
increasing concerns about the interaction of prefillable syringe components with the
pharmaceutical products, availability of less expensive and non-invasive alternatives,
necessity to adhere to stringent international standards and regulatory guidelines by
prefillable syringe manufacturers and threat of recalls of prefilled syringes are some of the
factors that are dampening the market growth.

The report covers business intelligence information and analysis of various PFS market
segments based on the material, design, closure system, product, application, molecule
type, usability, route of administration and geography. Glass PFS segment held the largest
share or revenue in 2021 and is expected to grow at a high single digit CAGR while Polymer
PFS segment is the fastest emerging segment that is expected of growing at a double digit
CAGR during the forecasted period. Single chamber prefilled syringes segment fetched the
largest revenue in 2021 and is expected of growing at a high single digit CAGR while Dual
chamber PFS segment is the fastest emerging segment that is expected of growing at a
double digit CAGR from 2021 to 2028. The segments of Staked Needle PFS, Large
molecule PFS, Subcutaneous PFS and Disposable PFS accounted for the largest revenue in
2021 and are also the fastest growing segments in their respective categories and these are
all expected of growing at a high single digit CAGR during the forecasted period. Complete
PFS Systems segment holds the largest revenue in 2021 and is expected to grow at a high
single digit CAGR while Accessory devices segment is the fastest emerging segment that is
expected of growing at a high single digit CAGR during the forecast period. The Heparin
PFS application segment accounted for the largest revenue in 2021 and is expected to grow
at a mid-single digit CAGR while Therapeutic Drugs PFS segment is the fastest emerging
segment that is expected of growing at a low teen CAGR from 2021 to 2028. Even though
Europe dominates the PFS market currently and is expected to grow at a mid-single digit
CAGR, Asia-Pacific region is the fastest emerging region that is expected of growing a
double digit CAGR during the forecasted period.

Technological advancements have aided in the transformation of prefilled syringes from

being an off-the-shelf commodity device to a highly customizable product incorporated with
value-enhancing human factor engineering features. The steadily growing space of PFS
market is substantiated by the ever expanding patent portfolio of PFS product companies,
the huge number of clinical trials for therapeutic drugs PFS and vaccine PFS and the

IQ4I Research & Consultancy Pvt. Ltd. Page 2

Prefilled Syringes Global Market

–Forecast to 2028

constantly increasing sales volume or number of units of PFS and heparin PFS across the
various regions and countries of the globe, especially in APAC region. U.S. and China
spearheaded the sales volume analysis of PFS units and heparin PFS units respectively.

The global COVID-19 pandemic which has been a blessing in disguise for the PFS industry
has led to significant increase in revenue of most of the players in the market owing to the
increased utilization of various PFS products for enabling need-of-the hour easier, safer and
convenient self-administration or home-based care and increased demand for saline flush
syringes during the pandemic, has triggered several research studies evaluating the
feasibility of prefillable syringes for packaging or encasing the high-in demand COVID-19
vaccine with very low temperature storage requisites and for facilitating safer, efficient and
quicker mass immunization programs and also led to the launch of advanced connected
PFS products to further support efficient home-based care.

The report also exemplifies and highlights the various organic and inorganic market
perpetuation strategies of leading players in the market.

Some of the prominent players in the fragmented PFS global market are Becton, Dickinson
And Company (U.S.), Gerresheimer AG (Germany), Schott AG (Germany), Nipro
Corporation (Japan), Terumo Corporation (Japan), Stevanato Group S.p.A (Italy), Shandong
Weigao Group Medical Polymer Company Limited (China), Owen Mumford LTD (U.K.),
Elcam Medical (Israel), Ypsomed Holdings AG (Switzerland) and others.

IQ4I Research & Consultancy Pvt. Ltd. Page 3

Prefilled Syringes Global Market

–Forecast to 2028

Reasons for buying this report:

 Prefilled Syringes global market is projected to reach $10,273.8 million by 2028.
 Identification and analysis of the prefilled syringes market based on material, design,
closure system, product, application, molecule type, usability, route of administration
and geography.
 Revenue forecast for prefilled syringes global market and strategic analysis of each
sub-segment with respect to segmental growth trends.
 Identification of major market trends, Porter's model and factors driving and
restraining prefilled syringes market growth.
 Region and Country specific analysis of Sales volume or Number of units of prefilled
syringes and heparin prefilled syringes, Analysis of Clinical trials, patent Trends of
major players, Market share analysis of prefilled syringes global market, Supply chain
analysis of prefilled syringes industry, Impact of COVID-19 on the industry and
prefilled syringes company - product comparison table based on product type
 Identification of key technological advancements in the prefillable syringes industry.
 Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
 Revenue forecast of prefilled syringes market with respect to North America (U.S.,
Rest of North America), Europe (Germany, Italy, France and Rest of Europe), Asia-
pacific (Japan, China, India and Rest of Asia-Pacific) and Rest of the World (Brazil,
Rest of Latin America and Middle East and Africa).
 Profiles of major players in prefilled syringes market and analysis of their product
offerings, financial revenue, business strategies, SWOTs and market shares.

IQ4I Research & Consultancy Pvt. Ltd. Page 4

Prefilled Syringes Global Market

–Forecast to 2028

FIGURE 1

PREFILLED SYRINGES GLOBAL MARKET SEGMENTATION

Prefilled Syringes Global Market

Closure Molecule
Material Design Application Product Usability ROA
System Type

Glass Single Staked Needle Heparin Complete Disposable Large Subcutaneous

Based PFS Chamber PFS PFS PFS PFS PFS Molecule PFS PFS

Polymer Dual Chamber Luer lock Vaccines Conventional Reusable Small Intramuscular
Based PFS PFS PFS PFS PFS PFS Molecule PFS PFS

Non-Luer lock Therapeutic Intravenous

Safety PFS PFS
PFS Drugs PFS

Other routes
Diluents PFS Consumables PFS

Surgical
Applications Accessory
Devices
PFS
Hyaluronic
Acid PFS
Other
Applications
PFS

Source: Parenteral Drug Association (PDA), Combination Products Coalition (CPC), Institute for Drug Delivery
and Biomedical Research (IDBER), Drug Delivery Foundation (DDF), International Federation of Pharmaceutical
Manufacturers & Association (IFPMA), Biomaterials and Drug Delivery Research Group (BADD), Association for
the Advancement of Medical Instrumentation (AAMI), International Organization For Standardization (ISO),
OECD, WHO, Industrial Experts and IQ4I Analysis.
*Note-ROA-Route of Administration

IQ4I Research & Consultancy Pvt. Ltd. Page 5